View organization detailsHide organization details
AI-first drug design and development company building a unified drug-design engine to advance new medicines.
Explore Cheminformatics jobs in blockchain and crypto. Find positions requiring Cheminformatics skills.
Daily open opportunities, newly observed postings, hiring breadth, and normalized monthly compensation for jobs in this pillar.
As of 2026-11-06
Distinct employers
+1 vs prior week
7 days vs previous 7 days
Remote pay is separated from onsite and hybrid pay so expensive cities do not distort the remote benchmark.
Onsite + hybrid
Limited evidence5 salaries from 3 employers
10 open jobs at 7 hiring companies
| Country market | Open jobs | Hiring companies | Median | Middle 50% | Evidence |
|---|---|---|---|---|---|
| United States | 5 | 4 | $10.4K/mo | $8.5K/mo – $15.7K/mo | 4 salaries from 2 employersLimited |
Open jobs are current; salary evidence covers the past 12 months and also uses closed postings. Every place rolls up through its canonical city, region, country, and continent hierarchy exactly once.
Open roles, employers, and newly listed jobs by day
Historical context; use the work-market split above for current pay
Earlier open counts are estimated from observation dates. Offline postings are never inferred open for more than 90 days; new daily samples are exact snapshots.
AI-first drug design and development company building a unified drug-design engine to advance new medicines.
AI-first drug design and development company building a unified drug-design engine to advance new medicines.
CuspAI·1 week ago
CuspAI is an AI-for-science company developing an AI platform for targeted materials discovery.
Investors
UK government research organisation that evaluates advanced AI risks and develops and tests mitigations to inform governments.
Funding
Investors
Clinical-stage life-science and technology company that develops medicines using an AI-driven discovery and development platform.
Funding
Investors
Boltz·1 month ago
Boltz PBC is an AI-for-science company building biomolecular models, compute infrastructure, and products for molecular design and discovery.
Funding
Clinical-stage life-science and technology company that develops medicines using an AI-driven discovery and development platform.
Funding
Investors
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
AI-first drug design and development company building a unified drug-design engine to advance new medicines.